SBC / revenue moved 714 bp higher
SBC / revenue changed +714 basis points from the comparable as-filed period.
2.07%→9.21%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MIND financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed across a sign change
Operating income changed -167.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$2.7M→-$1.8M3 prior comparisons
Capital expenditure decreased 40.7%
Capital expenditure changed -40.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$182,000→$108,0004 prior comparisons
Stock-based compensation increased 84.3%
Stock-based compensation changed +84.3% from the comparable as-filed period.
$281,000→$518,0003 prior comparisons
Working capital / assets moved 844 bp higher
Working capital / assets changed +844 basis points from the comparable as-filed period.
70.07%→78.51%3 prior comparisons
Receivables / revenue moved 18684 bp higher
Receivables / revenue changed +18684 basis points from the comparable as-filed period.
80.57%→267.41%2 prior comparisons
Current ratio increased 44.3%
Current ratio changed +44.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
4.79→6.924 prior comparisons
Shares outstanding increased 14.0%
Shares outstanding changed +14.0% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
7,969,421→9,089,0558 prior comparisons
Inventory decreased 10.9%
Inventory changed -10.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$11.8M→$10.5M4 prior comparisons
Capex / revenue moved 58 bp higher
Capex / revenue changed +58 basis points from the comparable as-filed period.
1.34%→1.92%3 prior comparisons
Selling, general & administrative decreased 10.5%
Selling, general & administrative changed -10.5% from the comparable as-filed period.
$3.6M→$3.3M3 prior comparisons
Current liabilities decreased 6.4%
Current liabilities changed -6.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$6.6M→$6.2M4 prior comparisons
Stock-based compensation increased 90.4%
Stock-based compensation changed +90.4% from the comparable as-filed period.
$272,000→$518,0003 prior comparisons
Current ratio increased 46.7%
Current ratio changed +46.7% from the comparable as-filed period.
3.55→5.23 prior comparisons
Receivables / revenue moved 7231 bp higher
Receivables / revenue changed +7231 basis points from the comparable as-filed period.
98.44%→170.75%2 prior comparisons
Working capital / assets moved 1153 bp higher
Working capital / assets changed +1153 basis points from the comparable as-filed period.
62.85%→74.38%3 prior comparisons
Operating income changed across a sign change
Operating income changed +102.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$658,000→$14,0003 prior comparisons
Inventory decreased 18.4%
Inventory changed -18.4% from the comparable as-filed period.
$13.4M→$11.0M3 prior comparisons
Shares outstanding increased 14.0%
Shares outstanding changed +14.0% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
7,969,421→9,089,0558 prior comparisons
Gross profit increased 23.0%
Gross profit changed +23.0% from the comparable as-filed period.
$3.3M→$4.1M3 prior comparisons
SBC / revenue moved 191 bp higher
SBC / revenue changed +191 basis points from the comparable as-filed period.
3.44%→5.36%3 prior comparisons
Research & development decreased 18.4%
Research & development changed -18.4% from the comparable as-filed period.
$380,000→$310,0003 prior comparisons
Gross margin moved 21 bp higher
Gross margin changed +21 basis points from the comparable as-filed period.
42.15%→42.36%3 prior comparisons
R&D / revenue moved 160 bp lower
R&D / revenue changed -160 basis points from the comparable as-filed period.
4.81%→3.21%3 prior comparisons
Current liabilities increased 0.5%
Current liabilities changed +0.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$8.9M→$9.0M3 prior comparisons
Selling, general & administrative increased 4.8%
Selling, general & administrative changed +4.8% from the comparable as-filed period.
$3.4M→$3.5M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.